R&D Engineer – Risk Management Owner for Acute Devices (m/w/d)

at  Baxter

VANTIVE: A NEW COMPANY BUILT ON OUR LEGACY

Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapies and home and in-center dialysis to provide best-in-class care to the people we serve. We believe Vantive will not only build our leadership in the kidney care space, it will also offer meaningful work to those who join us.

At Vantive, you will become part of a community of people who are focused, courageous and don’t settle for the mediocre. Each of us are driven to help improve patients’ lives worldwide. Join us as we revolutionize kidney care and other vital organ support.

• Completion of the proposed separation of Kidney Care from Baxter into a standalone company (to be named Vantive) remains subject to the satisfaction of customary conditions.

Am Standort Gambro Dialysatoren GmbH sind wir innerhalb des Baxter-Konzerns auf die Entwicklung und Herstellung von innovativen Dialysatoren und Dialyse-Kathetern spezialisiert. Rund 1.300 hochqualifizierte Mitarbeiter engagieren sich täglich die Lebensqualität von Patienten mit Nierenerkrankungen oder Nierenversagen zu verbessern.
Der Bereich Acute Dialyzers and Filters ist verantwortlich für Innovation, Entwicklung und Lebenszyklusmanagement für Dialysatoren, Filter und Katheter, die bei extrakorporalen Blutreinigungstherapien für Intensivpatienten eingesetzt werden. Innerhalb der R&D Abteilung übernehmen Sie folgende Aufgaben:

• Completion of the proposed separation of Kidney Care from Baxter into a standalone company (to be named Vantive) remains subject to the satisfaction of customary conditions